Cancer immunotherapy, mathematical modeling and optimal control

From MaRDI portal
Publication:2219776

DOI10.1016/j.jtbi.2007.04.003zbMath1455.92068OpenAlexW2081444498WikidataQ51913356 ScholiaQ51913356MaRDI QIDQ2219776

Benedetto Piccoli, Filippo Castiglione

Publication date: 21 January 2021

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2007.04.003




Related Items

Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approachA modified numerical method for bifurcations of fixed points of ODE systems with periodically pulsed inputsStudy of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancerA mathematical model for the dynamics of cancer hepatocytes under therapeutic actionsEffect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR modelOptimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approachInvestigating of an immune system-cancer mathematical model with Mittag-Leffler kernelMathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancerA time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysisOptimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapyT cell therapy against cancer: a predictive diffuse-interface mathematical model informed by pre-clinical studiesTHE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELINGImproved relaxations for the parametric solutions of ODEs using differential inequalitiesImplementation of fractional optimal control problems in real-world applicationsA mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancerA nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneityDynamics of fractional-order delay differential model for tumor-immune systemModeling pancreatic cancer dynamics with immunotherapyOptimal control for predicting customized drug dosage for superovulation stage of \textit{in vitro} fertilizationStability analysis of a mathematical model for glioma-immune interaction under optimal therapyMetaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparisonOPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITYModeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependentData-driven optimal control of a SEIR model for COVID-19Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemiaOptimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancerMathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokineBounding the dynamics of a chaotic-cancer mathematical modelOptimal control homotopy perturbation method for cancer modelOptimal CAR T-cell immunotherapy strategies for a leukemia treatment modelModeling the effect of immunotherapies on human castration-resistant prostate cancerDetermination of the optimal therapeutic protocols in cancer immunotherapyThe combined effects of optimal control in cancer remissionModelling pulsed immunotherapy of tumour-immune interactionAnalysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal controlA mathematical model of tumour growth with Beddington–DeAngelis functional response: a case of cancer without diseaseOptimal control of acute myeloid leukaemiaBifurcation analysis of a delayed mathematical model for tumor growthCost-effectiveness analysis of optimal strategy for tumor treatmentMaximization of viability time in a mathematical model of cancer therapyControlling IL-7 injections in HIV-infected patientsMathematical models for immunology: current state of the art and future research directionsSpatial avascular growth of tumor in a homogeneous environmentPersonalized medicine for in vitro fertilization procedure using modeling and optimal controlEvolutionary game based control for biological systems with applications in drug deliveryEquilibria and control of metabolic networks with enhancers and inhibitorsTREATMENT OF BLADDER CANCER USING BCG IMMUNOTHERAPY: PDE MODELINGFractional order model of immune cells influenced by cancer cellsA STRATEGY OF OPTIMAL EFFICACY OF T11 TARGET STRUCTURE IN THE TREATMENT OF BRAIN TUMORPractically scheduling hormone therapy for prostate cancer using a mathematical modelMixed therapy in cancer treatment for personalized drug administration using model reference adaptive controlPDE modeling of bladder cancer treatment using BCG immunotherapyAn agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological dataBifurcation analysis of the cancer virotherapy system with time delay and diffusionBacillus Calmette Guerin (BCG) immunotherapy for bladder cancer: a control and mathematical analysisMathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response



Cites Work

OSZAR »